Disminución de Costos de Transacción en la Formación de Clusters. Caso Biocluster de Occidente

Abstract

The pharmaceutical industry represents an opportunity for a better quality of life and preservation of people’s health worldwide. The million-selling industry has evolved over decades; the first pharmacy in Mexico appears in 1915, which led to the first laboratory in the country. Nowadays, Mexico is one of the largest pharmaceutical markets, giving space to transnational and national companies of great international importance. The interaction between government, universities and companies directly affects the success of the industry, which is why this linkage study is necessary. The creation of the first Biocluster in Mexico marks a new insight and a new age of knowledge, which involves co-benefits. For the purposes of this study, the focus on this model was to observe decrease in transaction costs.